Hester Biosciences Profile
Key Indicators
- Authorised Capital ₹ 11.20 Cr
as on 21-06-2024
- Paid Up Capital ₹ 8.51 Cr
as on 21-06-2024
- Company Age 37 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 202.60 Cr
as on 21-06-2024
- Satisfied Charges ₹ 89.54 Cr
as on 21-06-2024
- Revenue 15.77%
(FY 2023)
- Profit -18.16%
(FY 2023)
- Ebitda -9.38%
(FY 2023)
- Net Worth 8.92%
(FY 2023)
- Total Assets 28.60%
(FY 2023)
About Hester Biosciences
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524669 and on the National Stock Exchange(NSE) under HESTERBIO.
The Corporate was formerly known as Hester Pharmaceuticals Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 11.20 Cr and a paid-up capital of Rs 8.51 Cr.
The company currently has active open charges totaling ₹202.60 Cr. The company has closed loans amounting to ₹89.54 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Hester Biosciences Limited India are Nikhil Jhanwar as CFO and Vinodkumar Mali as Company Secretary. Ameetkumar Desai, Sanjiv Gandhi, Nina Gandhi, and Eight other members serve as directors at the Company.
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hester Biosciences Limited offer?
Hester Biosciences Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Common Disease Medicines, Anaemia Medicine, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Anti Infective Drugs & Medicines, HIV Drugs, Cholesterol Medicine, Muscle Relaxant.
Who are the key members and board of directors at Hester Biosciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Gandhi  | Managing Director | 29-Apr-1987 | Current |
| Nikhil Jhanwar | CFO | 09-Jun-2021 | Current |
| Vinodkumar Mali | Company Secretary | 14-May-2018 | Current |
Board Members(10)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Priya Gandhi | Whole-Time Director | 18-Oct-2014 | Current |
| Jatin Trivedi | Director | 26-Jun-2023 | Current |
| Ashok Bhimarao | Director | 01-Apr-2020 | Current |
| Ameetkumar Desai | Director | 28-Oct-2021 | Current |
| Sanjiv Gandhi | Director | 29-Apr-1987 | Current |
| Nina Gandhi | Alternate Director | 30-May-2014 | Current |
Financial Performance and Corporate Structure Insights of Hester Biosciences.
Hester Biosciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.77% increase. The company also saw a substantial fall in profitability, with a 18.16% decrease in profit. The company's net worth moved up by a moderate rise of 8.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hester Biosciences?
In 2023, Hester Biosciences had a promoter holding of 53.73% and a public holding of 46.27%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Hester Diagnostics Private LimitedActive 26 years 6 monthsSanjiv Gandhi, Nina Gandhi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 18 Dec 2021 | ₹91.08 Cr | Open |
Axis Bank Limited Creation Date: 26 Jul 2019 | ₹5.53 M | Open |
State Bank Of India Creation Date: 28 Dec 2013 | ₹110.97 Cr | Open |
How Many Employees Work at Hester Biosciences?
Hester Biosciences has a workforce of 695 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hester Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hester Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
